06-01 Revium Rx. Announces CFO Changes, Effective May 27, 2026 CI
05-14 Revium Rx. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-20 Revium Rx. Appoints Amir Avraham as Permanent Chief Executive Officer, Effective as of February 1, 2026 CI
04-20 Revium Rx. Appoints Shlomi Schwartzblat as Director and Chairman of the Board, Effective April 14, 2026 CI
03-31 Revium Rx. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-30 Revium Rx. Auditor Raises 'Going Concern' Doubt CI
01-16 Revium Rx. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-10-21 Revium Rx Advances Toward Phase 1 Clinical Development of Nano-Mupirocin to Combat Antibiotic-Resistant Infections GL
25-10-21 Revium Recovery Inc. Advances Toward Phase 1 Clinical Development of Nano-Mupirocin to Combat Antibiotic-Resistant Infections CI
25-10-03 Revium Rx. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-02-14 Revium Rx. has filed an IPO in the amount of $5 million. CI
25-02-04 Revium Rx (RVRC) Completes Acquisition of LipoVation Ltd. GL
25-02-03 Revium Recovery Inc. completed the acquisition of LipoVac, Ltd. CI
22-12-21 Revium Recovery, Inc. Announces Letter of Intent to Acquire LipoVac Ltd AQ
22-12-20 Revium Recovery, Inc. Announces Letter of Intent to Acquire LipoVac Ltd. AQ
22-12-19 Revium Recovery Inc. entered into a letter of intent to acquire LipoVac, Ltd. CI
21-01-07 Revium Recovery Inc. will Change its Ticker to RVRC from OCBG.D CI
20-12-17 Correction: REVIUM RECOVERY ACQUIRES ANTI-ADDICTION REHABILITATION BUSINESS GL
20-12-09 OC Beverages, Inc. has Changed its Name to Revium Recovery Inc CI
20-12-09 Revium Recovery Inc. has Changed its Ticker to OCBG.D from OCBG CI
No results match your criteria
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!